Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation

被引:267
作者
Babu, JR [1 ]
Geetha, T [1 ]
Wooten, MW [1 ]
机构
[1] Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, Auburn, AL 36849 USA
关键词
neurodegeneration; proteasome; tau; ubiquitin;
D O I
10.1111/j.1471-4159.2005.03181.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inclusions isolated from several neurodegenerative diseases, including Alzheimer's disease (AD), are characterized by ubiquitin-positive proteinaceous aggregates. Employing confocal and immunoelectron microscopy, we find that the ubiquitin-associating protein sequestosome1/p62, co-localizes to aggregates isolated from AD but not control brain, along with the E3 ubiquitin ligase, TRAF6. This interaction could be recapitulated by co-transfection in HEK293 cells. Employing both in vitro and in vivo approaches, tau was found to be a substrate of the TRAF6, possessing lysine 63 polyubiquitin chains. Moreover, tau recovered from brain of TRAF6 knockout mice, compared with wild type, was not ubiquitinated. Tau degradation took place through the ubiquitin-proteasome pathway and was dependent upon either the K63-polyubiquitin chains or upon p62. In brain lysates of p62 knockout mice, tau fails to co-interact with Rpt1, a proteasomal subunit, thereby indicating a requirement for p62 shuttling of tau to the proteasome. Our results demonstrate that p62 interacts with K63-polyubiquitinated tau through its UBA domain and serves a novel role in regulating tau proteasomal degradation. We propose a model whereby either a decline in p62 expression or a decrease in proteasome activity may contribute to accumulation of insoluble/aggregated K63-polyubiquitinated tau.
引用
收藏
页码:192 / 203
页数:12
相关论文
共 42 条
[1]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[2]   Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation [J].
Bennett, EJ ;
Bence, NF ;
Jayakumar, R ;
Kopito, RR .
MOLECULAR CELL, 2005, 17 (03) :351-365
[3]   Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone [J].
Ciani, B ;
Layfield, R ;
Cavey, JR ;
Sheppard, PW ;
Searle, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) :37409-37412
[4]   The ubiquitin proteasome system in neurodegenerative diseases: Sometimes the chicken, sometimes the egg [J].
Ciechanover, A ;
Brundin, P .
NEURON, 2003, 40 (02) :427-446
[5]   Proteasomal degradation of tau protein [J].
David, DC ;
Layfield, R ;
Serpell, L ;
Narain, Y ;
Goedert, M ;
Spillantini, MG .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (01) :176-185
[6]   The atypical PKC-interacting protein p62 is an important mediator of RANK-activated osteoclastogenesis [J].
Durán, A ;
Serrano, M ;
Leitges, M ;
Flores, JM ;
Picard, S ;
Brown, JP ;
Moscat, J ;
Diaz-Meco, MT .
DEVELOPMENTAL CELL, 2004, 6 (02) :303-309
[7]   Proteasome subunit Rpn1 binds ubiquitin-like protein domains [J].
Elsasser, S ;
Gali, RR ;
Schwickart, M ;
Larsen, CN ;
Leggett, DS ;
Müller, B ;
Feng, MT ;
Tübing, F ;
Dittmar, GAG ;
Finley, D .
NATURE CELL BIOLOGY, 2002, 4 (09) :725-730
[8]   Structure and functional properties of the ubiquitin binding protein p62 [J].
Geetha, T ;
Wooten, MW .
FEBS LETTERS, 2002, 512 (1-3) :19-24
[9]   Tau filament formation in transgenic mice expressing P301L tau [J].
Götz, J ;
Chen, F ;
Barmettler, R ;
Nitsch, RM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :529-534
[10]   AMYLOID BETA-PROTEIN INHIBITS UBIQUITIN-DEPENDENT PROTEIN-DEGRADATION IN-VITRO [J].
GREGORI, L ;
FUCHS, C ;
FIGUEIREDOPEREIRA, ME ;
VANNOSTRAND, WE ;
GOLDGABER, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19702-19708